sunny.png
Wednesday June 3rd, 2020 9:42AM

Merck 4Q net powered by cancer treatment sales, lower taxes

By The Associated Press
Related Articles
  Contact Editor

Higher medicine sales and lower restructuring and other costs lifted drugmaker Merck to a $1.83 billion profit in the fourth quarter, as it edged past Wall Street expectations.

The maker of blockbuster cancer drug Keytruda and Januvia diabetes pills lost $1.05 billion a year earlier, when it had a $2.92 billion tax bill due to a federal tax overhaul.

Merck shares rose in early trading, despite the drugmaker giving a 2019 financial forecast a bit below analysts' consensus.

The Kenilworth, New Jersey, drugmaker on Friday reported net income of 69 cents per share. Adjusted for multiple non-recurring costs, that amounted to $2.75 billion, or $1.04 per share, a penny better than analysts expected.

Revenue was $11 billion, slightly better than expected and up 5 percent from $10.43 billion in 2017's last quarter. Merck said unfavorable currency exchange rates reduced revenue by 3 percent in the quarter.

During a conference call to discuss the results, Chief Executive Kenneth Frazier told analysts that Merck's investments in research and development, and strong performance across its businesses, resulted in the "highest top- and bottom-line growth the company has seen in years, and we expect the momentum to carry over into 2019."

Sales of prescription drugs totaled $9.83 billion, up 6 percent.

Keytruda, an immuno-oncology that revs up the immune system to treat numerous cancer types, brought in $2.15 billion in the quarter. It generated $7.17 billion in 2018, up 88 percent, and now accounts for more than 20 percent of Merck & Co. revenue.

"We estimate Keytruda sales to exceed $15 billion by 2022. We believe this will lead to meaningful profit-margin expansion over the long term," Edward Jones analyst Ashtyn Evans wrote to investors.

During the quarter, Keytruda won U.S. approval for treating three more patient groups and now has approval for 11 different cancer types. Japan, one of the world's top markets for medicine, approved Keytruda for five different uses during the quarter.

Merck is testing the injected drug in many other cancer types, alone and in combination with other cancer treatments.

Vaccine sales also rose, led by $835 million for Merck's Gardasil 9 vaccine, which protects against a sexually transmitted virus that causes cancer.

But sales of Type 2 diabetes pills Januvia and Janumet, previously Merck's top-selling franchise, dipped to $1.47 billion as insurers continue pressing for lower prices and competition increases in the huge diabetes drug market. Januvia faces generic competition in 2022, but the company said sales of other drugs will make up for lost Januvia revenue.

Sales of veterinary medicines such as the Bravecto flea- and tick-killer for dogs jumped 6 percent to $1.04 billion.

"The company's animal health business and vaccines portfolio are performing well and provide diversification," Evans wrote, noting she thinks Merck's strong financial position will lead it to make acquisitions to supplement its internal drug development.

During 2018, China approved six Merck drugs, plus the use of Keytruda for treating three cancer types.

Merck said it expects full-year earnings in the range of $4.57 to $4.72 per share, with revenue in the range of $43.2 billion to $44.7 billion. Industry analysts had been projecting per-share earnings of $4.69, and revenue of $44.2 billion.

For all of 2018, Merck reported net income of $6.22 billion, or $2.32 per share — more than double its 2017 profit. Sales in 2018 totaled $42.29 billion, up 5 percent.

In morning trading, shares rose $2.40, or 3.2 percent, to $76.84.

_____

Follow Linda A. Johnson at https://twitter.com/LindaJ_onPharma

  • Associated Categories: Associated Press (AP), AP Business, AP Business - Corporate News, AP Business - Industries, AP Business - Health Care, AP Business - Personal Finance
© Copyright 2020 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
French security 'have right' to use weapons at protests
France's Council of State has ruled that security forces have a right to use controversial high-velocity rubber-ball launchers for crowd control at weekly protests by the yellow vest movement
8:05AM ( 17 minutes ago )
Midwest awaits spring-like thaw just days after bitter cold
Midwest awaits spring-like thaw just days after bitter cold; temperatures could climb by 80 degrees
8:00AM ( 21 minutes ago )
Special airlift for baby flamingos in peril in South Africa
Special airlift for baby flamingos in peril in South Africa amid drought; 3,000 moved so far
7:57AM ( 25 minutes ago )
Associated Press (AP)
India budget offers tax cuts, handouts for poor farmers
India's pre-election budget offers tax cuts, handouts for poor farmers
7:06AM ( 1 hour ago )
Grammys launch initiative aiding women producers, engineers
The Recording Academy's Task Force on Diversity and Inclusion is a launching a new initiative to create and expand more opportunities to female music producers and engineers
7:06AM ( 1 hour ago )
Merck 4Q powered by cancer treatment sales
Merck posts better than expected profit for the fourth quarter with revenue up 4.6 percent.
7:04AM ( 1 hour ago )
AP Business
Honda's profit drops on air bag recall expenses, flat sales
Honda logs 71 percent drop in profit in April-December as slow sales, air bag recalls take toll
3:11AM ( 5 hours ago )
Sony boosts profit on tax cut, yen, sales of music, movies
Sony boosts profit on tax cut, yen, entertainment segment
2:56AM ( 5 hours ago )
Schultz faces hometown protests as he eyes 2020 bid
Sonics fans, worried Democrats will greet talk by former Starbucks CEO Howard Schultz as he returns to Seattle
1:35AM ( 6 hours ago )
AP Business - Corporate News
Bangladesh sues Manila-based bank in NY over heist
Bangladesh central bank sues Philippine bank in New York court over 2016 heist of $81 million
2:39AM ( 5 hours ago )
Prescription discounts channeled to patients in Trump plan
Trump administration plan would channel behind-the-scenes drug discounts directly to patients
12:50AM ( 7 hours ago )
Trump plan would channel prescription discounts to patients
Trump administration plan would channel behind-the-scenes drug discounts directly to patients
7:55PM ( 12 hours ago )
AP Business - Industries
US stocks end mixed as Wall Street assesses earnings
Stocks posted an uneven finish on Wall Street Tuesday, handing the S&P 500 index its second decline in a row
5:32PM ( 2 days ago )
Early gains fade as Wall Street assesses earnings
Stocks are mostly lower as investors assess a mixed batch of corporate earnings and look ahead to a heavy schedule of news on companies and the economy
3:44PM ( 2 days ago )
GOP senator pledges insulin probe as Congress holds hearings
Senate committee opens hearings on high U.S. prescription drug prices and how the government might put the brakes on them. Pharmaceutical industry says price spikes of recent years have stabilized.
2:33PM ( 2 days ago )
AP Business - Health Care
US average mortgage rates edge up; 30-year at 4.46 percent
U.S. long-term mortgage rates edged up this week after declining over recent weeks. The average rate on the benchmark 30-year, fixed-rate mortgage rose to 4.46 percent from 4.45 percent last week.
12:00PM ( 20 hours ago )
Buying a home by age 35 is worth it now - and later
Becoming a first-time homeowner by age 35 may mean more wealth at retirement
11:25AM ( 20 hours ago )
Apple opens new chapter amid weakening iPhone demand
Apple CEO Tim Cook confronts toughest challenge yet as company grapples with slowing iPhone demand
10:26PM ( 2 days ago )
AP Business - Personal Finance
New Jersey Democratic Sen. Cory Booker launches 2020 bid
U.S. Sen. Cory Booker is running for president in 2020
8:20AM ( 2 minutes ago )
French security 'have right' to use weapons at protests
France's Council of State has ruled that security forces have a right to use controversial high-velocity rubber-ball launchers for crowd control at weekly protests by the yellow vest movement
8:05AM ( 17 minutes ago )
Midwest awaits spring-like thaw just days after bitter cold
Midwest awaits spring-like thaw just days after bitter cold; temperatures could climb by 80 degrees
8:00AM ( 21 minutes ago )
Special airlift for baby flamingos in peril in South Africa
Special airlift for baby flamingos in peril in South Africa amid drought; 3,000 moved so far
7:57AM ( 25 minutes ago )
A robust US job market likely defied shutdown during January
A robust US job market is thought to have defied partial government shutdown during January
7:54AM ( 28 minutes ago )